Timothy F. Donahue

Urology

353 E 68th St
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Comprehensive clinical and genomic analysis of early onset cancer of the bladder and upper urinary tract.

Comprehensive clinical and genomic analysis of early onset cancer of the bladder and upper urinary tract.

Journal: Journal of the National Cancer Institute

Published: December 22, 2025

Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 23, 2025

Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder Cancer.

Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 06, 2025

Evaluating Benefits of Peristomal Mesh Placement at the Time of Radical Cystectomy and Ileal Conduit Formation: A Phase 3, Randomized Controlled Trial.

Evaluating Benefits of Peristomal Mesh Placement at the Time of Radical Cystectomy and Ileal Conduit Formation: A Phase 3, Randomized Controlled Trial.

Journal: The Journal of urology

Published: August 08, 2025

Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical Trial.

Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical Trial.

Journal: JAMA surgery

Published: July 02, 2025

Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.

Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.

Journal: European urology

Published: April 22, 2025

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: January 13, 2025

Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer.

Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer.

Journal: Urologic oncology

Published: December 19, 2024

Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit.

Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit.

Journal: The Journal of urology

Published: December 12, 2024

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma.

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma.

Journal: European urology

Published: June 07, 2024

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.

Journal: JCO precision oncology

Published: May 01, 2024

Implementation and Validation of an Automated, Longitudinal Robotic Surgical Evaluation and Feedback Program at a High-volume Center and Impact on Training.

Implementation and Validation of an Automated, Longitudinal Robotic Surgical Evaluation and Feedback Program at a High-volume Center and Impact on Training.

Journal: European urology open science

Published: February 20, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026